Bronchodilator response during acute viral bronchiolitis in infancy.

Area of Science:

• Pediatrics
• Respiratory Medicine
• Infectious Diseases

Background:

• Acute bronchiolitis, primarily caused by respiratory syncytial virus (RSV), is a common respiratory infection in infants.
• Bronchodilator use in bronchiolitis is controversial, with varying responses observed in affected infants.

Purpose of the Study:

• To assess bronchodilator responsiveness in infants with acute RSV bronchiolitis.
• To identify factors differentiating bronchodilator responders from non-responders.
• To investigate the impact of environmental factors, such as maternal smoking, on bronchodilator response.

Main Methods:

• Fifty infants diagnosed with acute RSV bronchiolitis were enrolled.
• Specific respiratory conductance was measured before and after bronchodilator inhalation.
• Data on family history of atopy, eosinophil counts, immunoglobulin levels, and smoking exposure were collected.

Main Results:

• Thirty percent of infants demonstrated improved specific respiratory conductance after bronchodilator administration.
• No significant differences were found between responders and non-responders regarding atopy, eosinophil counts, or immunoglobulin levels.
• Infants of smoking mothers had lower baseline specific respiratory conductance, but bronchodilator response did not differ from infants of non-smoking mothers.

Conclusions:

• A subset of infants with RSV bronchiolitis exhibits bronchodilator responsiveness.
• Clinical predictors for identifying these responders are currently lacking.
• Maternal smoking is associated with reduced respiratory conductance in infants but does not appear to influence bronchodilator responsiveness in this cohort.